Augere Medical Secures MDR CE-mark for its PolypAId™ Software and System

The MDR CE-mark is an important milestone for Augere Medical, enabling European launch of Augere’s PolypAId™ System for artificial intelligence (AI) assisted detection of polyps during colonoscopy colon cancer screening. OSLO, Norway, Aug. 29, 2024 /PRNewswire/ — After more than 10 years…